Concepedia

Publication | Closed Access

Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma

DOI

195

Citations

13

References

2008

Year

Herbert Riechelmann, Alexander Sauter, Wolfram Golze, Gertraud Hanft, Carsten Schroen, Karl Hoermann, Thomas Erhardt, Silke Gronau
Oral Oncology

References

YearCitations

Page 1